Literature DB >> 17567797

Differential role of N-type calcium channel splice isoforms in pain.

Christophe Altier1, Camila S Dale, Alexandra E Kisilevsky, Kevin Chapman, Andrew J Castiglioni, Elizabeth A Matthews, Rhian M Evans, Anthony H Dickenson, Diane Lipscombe, Nathalie Vergnolle, Gerald W Zamponi.   

Abstract

N-type calcium channels are essential mediators of spinal nociceptive transmission. The core subunit of the N-type channel is encoded by a single gene, and multiple N-type channel isoforms can be generated by alternate splicing. In particular, cell-specific inclusion of an alternatively spliced exon 37a generates a novel form of the N-type channel that is highly enriched in nociceptive neurons and, as we show here, downregulated in a neuropathic pain model. Splice isoform-specific small interfering RNA silencing in vivo reveals that channels containing exon 37a are specifically required for mediating basal thermal nociception and for developing thermal and mechanical hyperalgesia during inflammatory and neuropathic pain. In contrast, both N-type channel isoforms (e37a- and e37b-containing) contribute to tactile neuropathic allodynia. Hence, exon 37a acts as a molecular switch that tailors the channels toward specific roles in pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567797      PMCID: PMC6672448          DOI: 10.1523/JNEUROSCI.0307-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

Review 1.  Ion channels in presynaptic nerve terminals and control of transmitter release.

Authors:  A Meir; S Ginsburg; A Butkevich; S G Kachalsky; I Kaiserman; R Ahdut; S Demirgoren; R Rahamimoff
Journal:  Physiol Rev       Date:  1999-07       Impact factor: 37.312

2.  alpha 1B N-type calcium channel isoforms with distinct biophysical properties.

Authors:  A Stea; S J Dubel; T P Snutch
Journal:  Ann N Y Acad Sci       Date:  1999-04-30       Impact factor: 5.691

3.  Alternative splicing of a short cassette exon in alpha1B generates functionally distinct N-type calcium channels in central and peripheral neurons.

Authors:  Z Lin; Y Lin; S Schorge; J Q Pan; M Beierlein; D Lipscombe
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

4.  Adverse effects associated with the intrathecal administration of ziconotide.

Authors:  R D Penn; J A Paice
Journal:  Pain       Date:  2000-03       Impact factor: 6.961

Review 5.  Ion channels of nociception.

Authors:  E W McCleskey; M S Gold
Journal:  Annu Rev Physiol       Date:  1999       Impact factor: 19.318

6.  Association of neuronal calcium channels with modular adaptor proteins.

Authors:  A Maximov; T C Südhof; I Bezprozvanny
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

7.  Role of N-type calcium channels in autonomic neurotransmission in guinea-pig isolated left atria.

Authors:  A P Serone; J A Angus
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

Review 8.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

9.  Synthesis and biological evaluation of substituted 4-(OBz)phenylalanine derivatives as novel N-type calcium channel blockers.

Authors:  L Y Hu; T R Ryder; S S Nikam; E Millerman; B G Szoke; M F Rafferty
Journal:  Bioorg Med Chem Lett       Date:  1999-04-19       Impact factor: 2.823

Review 10.  Neuropathic pain: aetiology, symptoms, mechanisms, and management.

Authors:  C J Woolf; R J Mannion
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

View more
  70 in total

1.  A PEPTIDE UNCOUPLING CRMP-2 FROM THE PRESYNAPTIC Ca(2+) CHANNEL COMPLEX DEMONSTRATES EFFICACY IN ANIMAL MODELS OF MIGRAINE AND AIDS THERAPY-INDUCED NEUROPATHY.

Authors:  Matthew S Ripsch; Carrie J Ballard; May Khanna; Joyce H Hurley; Fletcher A White; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2012-03       Impact factor: 1.757

2.  Subtype-specific reduction of voltage-gated calcium current in medium-sized dorsal root ganglion neurons after painful peripheral nerve injury.

Authors:  J B McCallum; H-E Wu; Q Tang; W-M Kwok; Q H Hogan
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

Review 3.  Trafficking and stability of voltage-gated calcium channels.

Authors:  Brett A Simms; Gerald W Zamponi
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

Review 4.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 5.  Calcium channel functions in pain processing.

Authors:  John Park; Z David Luo
Journal:  Channels (Austin)       Date:  2010-11-01       Impact factor: 2.581

6.  Src family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors.

Authors:  Guohua Zhang; Wenling Chen; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

7.  Alternative Splicing in Ca(V)2.2 Regulates Neuronal Trafficking via Adaptor Protein Complex-1 Adaptor Protein Motifs.

Authors:  Natsuko Macabuag; Annette C Dolphin
Journal:  J Neurosci       Date:  2015-10-28       Impact factor: 6.167

Review 8.  Alternative splicing of voltage-gated calcium channels: from molecular biology to disease.

Authors:  Ping Liao; Heng Yu Zhang; Tuck Wah Soong
Journal:  Pflugers Arch       Date:  2009-01-17       Impact factor: 3.657

9.  μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.

Authors:  W Chen; J A McRoberts; J C G Marvizón
Journal:  Neuroscience       Date:  2014-02-26       Impact factor: 3.590

Review 10.  Regulation of voltage-gated calcium channels by proteolysis.

Authors:  Kathryn Abele; Jian Yang
Journal:  Sheng Li Xue Bao       Date:  2012-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.